General News

Sanford Health, Inanovate Seek Cancer Blood Test for Clinics

Test looks for increasing antibodies to predict breast cancer recurrence June 28, 2018 SIOUX FALLS, S.D. – A Sanford Research scientist has developed a promising blood test that uses a patient’s own immune system as a biosensor to detect breast cancer. The application has been licensed to Inanovate, a medical technology company specializing in screening and analysis of …

Read More

Sanford Health Enters Agreement to Develop Infusion System

Drug infusion device more versatile, less expensive June 6, 2018 SIOUX FALLS, S.D. – Sanford Health and Freudenberg Medical, a global developer and manufacturer for the medical device industry, have entered into a joint research and development agreement to create a device to treat blood clots and blockages within blood vessels. The catheter will infuse …

Read More

Sanford Health and University of South Dakota Collaborate
to Develop DCBs with Precise Drug Delivery for PAD Treatment

December 16, 2015 Sanford Health and the University of South Dakota (USD) announced that they are collaborating to develop more effective drug-coated balloons (DCBs) to treat peripheral artery disease. The two new devices, which can more precisely deliver drugs to specific arteries, are based on intellectual property jointly created by Sanford’s Patrick Kelly, MD, and USD’s …

Read More

Research Spotlight: Scientists Explore Novel Approaches to Peripheral Artery Disease, Head and Neck Cancer

The University of South Dakota and Sanford Health are collaborating to develop more effective drug-coated balloons to treat peripheral artery disease.

Read More

First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study

Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation’s largest health care systems, today announced the first patient enrolled in a clinical study using the Medtronic Valiant® TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm.

Read More

The Lifesaving Power of Increased Treatment Options

February 22, 2016 Biomedical research studies conducted on human participants are universally known in the profession as “clinical trials”. But for the President of Research at Sanford Health, the term is just too limited. “I prefer the phrase ‘increased treatment options’, because that’s what clinical trials really are,” says David Pearce, PhD, Senior Scientist with …

Read More

Patrick Kelly’s Precarious Path to Being a Vascular Visionary

Earlier this month, Medtronic, the global medical device goliath, announced that it had enrolled a patient into a study of an aortic stent developed by Kelly and his team at Sanford.

Read More

Obtaining an IDE for Physician-Modified or Off-Label Stent Grafts

A physician’s perspective on applying for an IDE, interaction with the FDA, and practice under an IDE.

Read More

FDA Approves Study of New Aneurysm Device Developed by Sanford Health

June 21, 2016 Unitary Manifold Stent Graft System designed by Dr. Patrick Kelly SIOUX FALLS, S.D. – Sanford Vascular Innovations, a division of Sanford Health working on technology to improve vascular surgery and endovascular care, has been approved by the FDA to study a new device to treat complex aneurysms occurring in the descending aorta. The …

Read More

Low Early Mortality and High Technical Success for Novel Thoracic Stent Graft

May 16, 2018 A physician-sponsored investigational device exemption trial on thoracic endovascular aortic repair (TEVAR) using a new thoracic stent graft (Valiant thoracoabdominal aortic aneurysm stent graft, Medtronic), along with its initial 30-day data, was revealed at a Podium 1st presentation at CX 2018 by Thomas Maldonado (New York, USA). The early results showed high …

Read More

Fluid Flow Model Evaluates Clotting Risk in New Stent Graft Design

South Dakota State University associate professor Stephen Gent collaborated with Sanford Health vascular surgeon Dr. Pat Kelly and biomedical engineer Tyler Remund to evaluate whether a new branching stent design might increase the risk of blood clots.

Read More

Sanford surgeon, Boston Scientific collaborate to develop device

June 6, 2017 SIOUX FALLS, S.D. – Patrick Kelly, M.D., with Sanford Vascular Innovations, a division of Sanford Health, will collaborate with Boston Scientific, a global medical technology leader, to develop a device that could transform treatment for life-threatening blood clots in the lungs, known as pulmonary embolisms. Dr. Kelly has invented a less-invasive catheter system …

Read More